カテゴリー： 世界, 医療/バイオ, LP Information

世界のテリパラチド原薬市場予測 2023年-2029年

【英語タイトル】Global Teriparatide API Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC02862）・商品コード：LP23DC02862
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：94
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医療機器＆消耗品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のテリパラチド原薬市場」は、過去の販売実績から2022年の世界のテリパラチド原薬の総販売量を検討し、2023年から2029年の予測されるテリパラチド原薬の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のテリパラチド原薬の市場規模を掲載し、XXX百万米ドル規模の世界のテリパラチド原薬市場の詳細な分析を提供します。本インサイトレポートは、世界のテリパラチド原薬業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のテリパラチド原薬市場における各社の独自のポジションをより深く理解するために、テリパラチド原薬製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のテリパラチド原薬市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。テリパラチド原薬の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。テリパラチド原薬の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。テリパラチド原薬のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

テリパラチド原薬の世界主要メーカーとしては、Hybio Pharmaceutical Co Ltd、 Sun Pharmaceutical Industries Ltd、 Msn Life Sciences Private Ltd、 Amphastar Nanjing Pharmaceuticals Inc、 Chengdu Shengnuo Biopharm Co Ltd、 Scinopharm Taiwan Ltd、 Auro Peptides Ltd、 Ambiopharm Inc、 Richter-Helm Biotec Gmbh And Co Kgなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のテリパラチド原薬市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではテリパラチド原薬市場をセグメンテーションし、種類別 (純度≧99%、純度<99%)、用途別 (注射、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：純度≧99%、純度<99%

・用途別区分：注射、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界のテリパラチド原薬市場の10年間の市場状況・展望は？
・世界および地域別に見たテリパラチド原薬市場成長の要因は何か？
・テリパラチド原薬の市場機会はエンドマーケットの規模によってどのように変化するのか？
・テリパラチド原薬のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：テリパラチド原薬の年間販売量2018-2029、地域別現状・将来分析
・テリパラチド原薬の種類別セグメント：純度≧99%、純度<99%
・テリパラチド原薬の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・テリパラチド原薬の用途別セグメント：注射、その他
・テリパラチド原薬の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のテリパラチド原薬市場
・企業別のグローバルテリパラチド原薬市場データ：2018-2023年の年間販売量、市場シェア
・企業別のテリパラチド原薬の年間売上：2018-2023年の売上、市場シェア
・企業別のテリパラチド原薬販売価格
・主要企業のテリパラチド原薬生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

テリパラチド原薬の地域別レビュー
・地域別のテリパラチド原薬市場規模2018-2023：年間販売量、売上
・主要国別のテリパラチド原薬市場規模2018-2023：年間販売量、売上
・南北アメリカのテリパラチド原薬販売の成長
・アジア太平洋のテリパラチド原薬販売の成長
・ヨーロッパのテリパラチド原薬販売の成長
・中東・アフリカのテリパラチド原薬販売の成長

南北アメリカ市場
・南北アメリカの国別のテリパラチド原薬販売量、売上（2018-2023）
・南北アメリカのテリパラチド原薬の種類別販売量
・南北アメリカのテリパラチド原薬の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のテリパラチド原薬販売量、売上（2018-2023）
・アジア太平洋のテリパラチド原薬の種類別販売量
・アジア太平洋のテリパラチド原薬の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のテリパラチド原薬販売量、売上（2018-2023）
・ヨーロッパのテリパラチド原薬の種類別販売量
・ヨーロッパのテリパラチド原薬の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のテリパラチド原薬販売量、売上（2018-2023）
・中東・アフリカのテリパラチド原薬の種類別販売量
・中東・アフリカのテリパラチド原薬の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・テリパラチド原薬の製造コスト構造分析
・テリパラチド原薬の製造プロセス分析
・テリパラチド原薬の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・テリパラチド原薬の主要なグローバル販売業者
・テリパラチド原薬の主要なグローバル顧客

地域別のテリパラチド原薬市場予測レビュー
・地域別のテリパラチド原薬市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・テリパラチド原薬の種類別市場規模予測
・テリパラチド原薬の用途別市場規模予測

主要企業分析
Hybio Pharmaceutical Co Ltd、 Sun Pharmaceutical Industries Ltd、 Msn Life Sciences Private Ltd、 Amphastar Nanjing Pharmaceuticals Inc、 Chengdu Shengnuo Biopharm Co Ltd、 Scinopharm Taiwan Ltd、 Auro Peptides Ltd、 Ambiopharm Inc、 Richter-Helm Biotec Gmbh And Co Kg
・企業情報
・テリパラチド原薬製品
・テリパラチド原薬販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Teriparatide API market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Teriparatide API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Teriparatide API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Teriparatide API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Teriparatide API players cover Hybio Pharmaceutical Co Ltd, Sun Pharmaceutical Industries Ltd, Msn Life Sciences Private Ltd, Amphastar Nanjing Pharmaceuticals Inc, Chengdu Shengnuo Biopharm Co Ltd, Scinopharm Taiwan Ltd, Auro Peptides Ltd, Ambiopharm Inc and Richter-Helm Biotec Gmbh And Co Kg, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)’ newest research report, the “Teriparatide API Industry Forecast” looks at past sales and reviews total world Teriparatide API sales in 2022, providing a comprehensive analysis by region and market sector of projected Teriparatide API sales for 2023 through 2029. With Teriparatide API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Teriparatide API industry.
This Insight Report provides a comprehensive analysis of the global Teriparatide API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Teriparatide API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Teriparatide API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Teriparatide API and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Teriparatide API.
This report presents a comprehensive overview, market shares, and growth opportunities of Teriparatide API market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Purity≥99%
Purity<99% Segmentation by application Injection Others This report also splits the market by region: Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration. Hybio Pharmaceutical Co Ltd Sun Pharmaceutical Industries Ltd Msn Life Sciences Private Ltd Amphastar Nanjing Pharmaceuticals Inc Chengdu Shengnuo Biopharm Co Ltd Scinopharm Taiwan Ltd Auro Peptides Ltd Ambiopharm Inc Richter-Helm Biotec Gmbh And Co Kg Key Questions Addressed in this Report What is the 10-year outlook for the global Teriparatide API market? What factors are driving Teriparatide API market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Teriparatide API market opportunities vary by end market size? How does Teriparatide API break out type, application? What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Teriparatide API Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Teriparatide API by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Teriparatide API by Country/Region, 2018, 2022 & 2029
2.2 Teriparatide API Segment by Type
2.2.1 Purity≥99%
2.2.2 Purity<99% 2.3 Teriparatide API Sales by Type 2.3.1 Global Teriparatide API Sales Market Share by Type (2018-2023) 2.3.2 Global Teriparatide API Revenue and Market Share by Type (2018-2023) 2.3.3 Global Teriparatide API Sale Price by Type (2018-2023) 2.4 Teriparatide API Segment by Application 2.4.1 Injection 2.4.2 Others 2.5 Teriparatide API Sales by Application 2.5.1 Global Teriparatide API Sale Market Share by Application (2018-2023) 2.5.2 Global Teriparatide API Revenue and Market Share by Application (2018-2023) 2.5.3 Global Teriparatide API Sale Price by Application (2018-2023) 3 Global Teriparatide API by Company 3.1 Global Teriparatide API Breakdown Data by Company 3.1.1 Global Teriparatide API Annual Sales by Company (2018-2023) 3.1.2 Global Teriparatide API Sales Market Share by Company (2018-2023) 3.2 Global Teriparatide API Annual Revenue by Company (2018-2023) 3.2.1 Global Teriparatide API Revenue by Company (2018-2023) 3.2.2 Global Teriparatide API Revenue Market Share by Company (2018-2023) 3.3 Global Teriparatide API Sale Price by Company 3.4 Key Manufacturers Teriparatide API Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Teriparatide API Product Location Distribution 3.4.2 Players Teriparatide API Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for Teriparatide API by Geographic Region 4.1 World Historic Teriparatide API Market Size by Geographic Region (2018-2023) 4.1.1 Global Teriparatide API Annual Sales by Geographic Region (2018-2023) 4.1.2 Global Teriparatide API Annual Revenue by Geographic Region (2018-2023) 4.2 World Historic Teriparatide API Market Size by Country/Region (2018-2023) 4.2.1 Global Teriparatide API Annual Sales by Country/Region (2018-2023) 4.2.2 Global Teriparatide API Annual Revenue by Country/Region (2018-2023) 4.3 Americas Teriparatide API Sales Growth 4.4 APAC Teriparatide API Sales Growth 4.5 Europe Teriparatide API Sales Growth 4.6 Middle East & Africa Teriparatide API Sales Growth 5 Americas 5.1 Americas Teriparatide API Sales by Country 5.1.1 Americas Teriparatide API Sales by Country (2018-2023) 5.1.2 Americas Teriparatide API Revenue by Country (2018-2023) 5.2 Americas Teriparatide API Sales by Type 5.3 Americas Teriparatide API Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Teriparatide API Sales by Region 6.1.1 APAC Teriparatide API Sales by Region (2018-2023) 6.1.2 APAC Teriparatide API Revenue by Region (2018-2023) 6.2 APAC Teriparatide API Sales by Type 6.3 APAC Teriparatide API Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Teriparatide API by Country 7.1.1 Europe Teriparatide API Sales by Country (2018-2023) 7.1.2 Europe Teriparatide API Revenue by Country (2018-2023) 7.2 Europe Teriparatide API Sales by Type 7.3 Europe Teriparatide API Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Teriparatide API by Country 8.1.1 Middle East & Africa Teriparatide API Sales by Country (2018-2023) 8.1.2 Middle East & Africa Teriparatide API Revenue by Country (2018-2023) 8.2 Middle East & Africa Teriparatide API Sales by Type 8.3 Middle East & Africa Teriparatide API Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Teriparatide API 10.3 Manufacturing Process Analysis of Teriparatide API 10.4 Industry Chain Structure of Teriparatide API 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Teriparatide API Distributors 11.3 Teriparatide API Customer 12 World Forecast Review for Teriparatide API by Geographic Region 12.1 Global Teriparatide API Market Size Forecast by Region 12.1.1 Global Teriparatide API Forecast by Region (2024-2029) 12.1.2 Global Teriparatide API Annual Revenue Forecast by Region (2024-2029) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global Teriparatide API Forecast by Type 12.7 Global Teriparatide API Forecast by Application 13 Key Players Analysis 13.1 Hybio Pharmaceutical Co Ltd 13.1.1 Hybio Pharmaceutical Co Ltd Company Information 13.1.2 Hybio Pharmaceutical Co Ltd Teriparatide API Product Portfolios and Specifications 13.1.3 Hybio Pharmaceutical Co Ltd Teriparatide API Sales, Revenue, Price and Gross Margin (2018-2023) 13.1.4 Hybio Pharmaceutical Co Ltd Main Business Overview 13.1.5 Hybio Pharmaceutical Co Ltd Latest Developments 13.2 Sun Pharmaceutical Industries Ltd 13.2.1 Sun Pharmaceutical Industries Ltd Company Information 13.2.2 Sun Pharmaceutical Industries Ltd Teriparatide API Product Portfolios and Specifications 13.2.3 Sun Pharmaceutical Industries Ltd Teriparatide API Sales, Revenue, Price and Gross Margin (2018-2023) 13.2.4 Sun Pharmaceutical Industries Ltd Main Business Overview 13.2.5 Sun Pharmaceutical Industries Ltd Latest Developments 13.3 Msn Life Sciences Private Ltd 13.3.1 Msn Life Sciences Private Ltd Company Information 13.3.2 Msn Life Sciences Private Ltd Teriparatide API Product Portfolios and Specifications 13.3.3 Msn Life Sciences Private Ltd Teriparatide API Sales, Revenue, Price and Gross Margin (2018-2023) 13.3.4 Msn Life Sciences Private Ltd Main Business Overview 13.3.5 Msn Life Sciences Private Ltd Latest Developments 13.4 Amphastar Nanjing Pharmaceuticals Inc 13.4.1 Amphastar Nanjing Pharmaceuticals Inc Company Information 13.4.2 Amphastar Nanjing Pharmaceuticals Inc Teriparatide API Product Portfolios and Specifications 13.4.3 Amphastar Nanjing Pharmaceuticals Inc Teriparatide API Sales, Revenue, Price and Gross Margin (2018-2023) 13.4.4 Amphastar Nanjing Pharmaceuticals Inc Main Business Overview 13.4.5 Amphastar Nanjing Pharmaceuticals Inc Latest Developments 13.5 Chengdu Shengnuo Biopharm Co Ltd 13.5.1 Chengdu Shengnuo Biopharm Co Ltd Company Information 13.5.2 Chengdu Shengnuo Biopharm Co Ltd Teriparatide API Product Portfolios and Specifications 13.5.3 Chengdu Shengnuo Biopharm Co Ltd Teriparatide API Sales, Revenue, Price and Gross Margin (2018-2023) 13.5.4 Chengdu Shengnuo Biopharm Co Ltd Main Business Overview 13.5.5 Chengdu Shengnuo Biopharm Co Ltd Latest Developments 13.6 Scinopharm Taiwan Ltd 13.6.1 Scinopharm Taiwan Ltd Company Information 13.6.2 Scinopharm Taiwan Ltd Teriparatide API Product Portfolios and Specifications 13.6.3 Scinopharm Taiwan Ltd Teriparatide API Sales, Revenue, Price and Gross Margin (2018-2023) 13.6.4 Scinopharm Taiwan Ltd Main Business Overview 13.6.5 Scinopharm Taiwan Ltd Latest Developments 13.7 Auro Peptides Ltd 13.7.1 Auro Peptides Ltd Company Information 13.7.2 Auro Peptides Ltd Teriparatide API Product Portfolios and Specifications 13.7.3 Auro Peptides Ltd Teriparatide API Sales, Revenue, Price and Gross Margin (2018-2023) 13.7.4 Auro Peptides Ltd Main Business Overview 13.7.5 Auro Peptides Ltd Latest Developments 13.8 Ambiopharm Inc 13.8.1 Ambiopharm Inc Company Information 13.8.2 Ambiopharm Inc Teriparatide API Product Portfolios and Specifications 13.8.3 Ambiopharm Inc Teriparatide API Sales, Revenue, Price and Gross Margin (2018-2023) 13.8.4 Ambiopharm Inc Main Business Overview 13.8.5 Ambiopharm Inc Latest Developments 13.9 Richter-Helm Biotec Gmbh And Co Kg 13.9.1 Richter-Helm Biotec Gmbh And Co Kg Company Information 13.9.2 Richter-Helm Biotec Gmbh And Co Kg Teriparatide API Product Portfolios and Specifications 13.9.3 Richter-Helm Biotec Gmbh And Co Kg Teriparatide API Sales, Revenue, Price and Gross Margin (2018-2023) 13.9.4 Richter-Helm Biotec Gmbh And Co Kg Main Business Overview 13.9.5 Richter-Helm Biotec Gmbh And Co Kg Latest Developments 14 Research Findings and Conclusion

List of Tables
Table 1. Teriparatide API Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Teriparatide API Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Purity≥99%
Table 4. Major Players of Purity<99%
Table 5. Global Teriparatide API Sales by Type (2018-2023) & (Tons)
Table 6. Global Teriparatide API Sales Market Share by Type (2018-2023)
Table 7. Global Teriparatide API Revenue by Type (2018-2023) & ($ million)
Table 8. Global Teriparatide API Revenue Market Share by Type (2018-2023)
Table 9. Global Teriparatide API Sale Price by Type (2018-2023) & (US$/Ton)
Table 10. Global Teriparatide API Sales by Application (2018-2023) & (Tons)
Table 11. Global Teriparatide API Sales Market Share by Application (2018-2023)
Table 12. Global Teriparatide API Revenue by Application (2018-2023)
Table 13. Global Teriparatide API Revenue Market Share by Application (2018-2023)
Table 14. Global Teriparatide API Sale Price by Application (2018-2023) & (US$/Ton)
Table 15. Global Teriparatide API Sales by Company (2018-2023) & (Tons)
Table 16. Global Teriparatide API Sales Market Share by Company (2018-2023)
Table 17. Global Teriparatide API Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Teriparatide API Revenue Market Share by Company (2018-2023)
Table 19. Global Teriparatide API Sale Price by Company (2018-2023) & (US$/Ton)
Table 20. Key Manufacturers Teriparatide API Producing Area Distribution and Sales Area
Table 21. Players Teriparatide API Products Offered
Table 22. Teriparatide API Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Teriparatide API Sales by Geographic Region (2018-2023) & (Tons)
Table 26. Global Teriparatide API Sales Market Share Geographic Region (2018-2023)
Table 27. Global Teriparatide API Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Teriparatide API Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Teriparatide API Sales by Country/Region (2018-2023) & (Tons)
Table 30. Global Teriparatide API Sales Market Share by Country/Region (2018-2023)
Table 31. Global Teriparatide API Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Teriparatide API Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Teriparatide API Sales by Country (2018-2023) & (Tons)
Table 34. Americas Teriparatide API Sales Market Share by Country (2018-2023)
Table 35. Americas Teriparatide API Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Teriparatide API Revenue Market Share by Country (2018-2023)
Table 37. Americas Teriparatide API Sales by Type (2018-2023) & (Tons)
Table 38. Americas Teriparatide API Sales by Application (2018-2023) & (Tons)
Table 39. APAC Teriparatide API Sales by Region (2018-2023) & (Tons)
Table 40. APAC Teriparatide API Sales Market Share by Region (2018-2023)
Table 41. APAC Teriparatide API Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Teriparatide API Revenue Market Share by Region (2018-2023)
Table 43. APAC Teriparatide API Sales by Type (2018-2023) & (Tons)
Table 44. APAC Teriparatide API Sales by Application (2018-2023) & (Tons)
Table 45. Europe Teriparatide API Sales by Country (2018-2023) & (Tons)
Table 46. Europe Teriparatide API Sales Market Share by Country (2018-2023)
Table 47. Europe Teriparatide API Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Teriparatide API Revenue Market Share by Country (2018-2023)
Table 49. Europe Teriparatide API Sales by Type (2018-2023) & (Tons)
Table 50. Europe Teriparatide API Sales by Application (2018-2023) & (Tons)
Table 51. Middle East & Africa Teriparatide API Sales by Country (2018-2023) & (Tons)
Table 52. Middle East & Africa Teriparatide API Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Teriparatide API Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Teriparatide API Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Teriparatide API Sales by Type (2018-2023) & (Tons)
Table 56. Middle East & Africa Teriparatide API Sales by Application (2018-2023) & (Tons)
Table 57. Key Market Drivers & Growth Opportunities of Teriparatide API
Table 58. Key Market Challenges & Risks of Teriparatide API
Table 59. Key Industry Trends of Teriparatide API
Table 60. Teriparatide API Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Teriparatide API Distributors List
Table 63. Teriparatide API Customer List
Table 64. Global Teriparatide API Sales Forecast by Region (2024-2029) & (Tons)
Table 65. Global Teriparatide API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Teriparatide API Sales Forecast by Country (2024-2029) & (Tons)
Table 67. Americas Teriparatide API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Teriparatide API Sales Forecast by Region (2024-2029) & (Tons)
Table 69. APAC Teriparatide API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Teriparatide API Sales Forecast by Country (2024-2029) & (Tons)
Table 71. Europe Teriparatide API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Teriparatide API Sales Forecast by Country (2024-2029) & (Tons)
Table 73. Middle East & Africa Teriparatide API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Teriparatide API Sales Forecast by Type (2024-2029) & (Tons)
Table 75. Global Teriparatide API Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Teriparatide API Sales Forecast by Application (2024-2029) & (Tons)
Table 77. Global Teriparatide API Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Hybio Pharmaceutical Co Ltd Basic Information, Teriparatide API Manufacturing Base, Sales Area and Its Competitors
Table 79. Hybio Pharmaceutical Co Ltd Teriparatide API Product Portfolios and Specifications
Table 80. Hybio Pharmaceutical Co Ltd Teriparatide API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 81. Hybio Pharmaceutical Co Ltd Main Business
Table 82. Hybio Pharmaceutical Co Ltd Latest Developments
Table 83. Sun Pharmaceutical Industries Ltd Basic Information, Teriparatide API Manufacturing Base, Sales Area and Its Competitors
Table 84. Sun Pharmaceutical Industries Ltd Teriparatide API Product Portfolios and Specifications
Table 85. Sun Pharmaceutical Industries Ltd Teriparatide API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 86. Sun Pharmaceutical Industries Ltd Main Business
Table 87. Sun Pharmaceutical Industries Ltd Latest Developments
Table 88. Msn Life Sciences Private Ltd Basic Information, Teriparatide API Manufacturing Base, Sales Area and Its Competitors
Table 89. Msn Life Sciences Private Ltd Teriparatide API Product Portfolios and Specifications
Table 90. Msn Life Sciences Private Ltd Teriparatide API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 91. Msn Life Sciences Private Ltd Main Business
Table 92. Msn Life Sciences Private Ltd Latest Developments
Table 93. Amphastar Nanjing Pharmaceuticals Inc Basic Information, Teriparatide API Manufacturing Base, Sales Area and Its Competitors
Table 94. Amphastar Nanjing Pharmaceuticals Inc Teriparatide API Product Portfolios and Specifications
Table 95. Amphastar Nanjing Pharmaceuticals Inc Teriparatide API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 96. Amphastar Nanjing Pharmaceuticals Inc Main Business
Table 97. Amphastar Nanjing Pharmaceuticals Inc Latest Developments
Table 98. Chengdu Shengnuo Biopharm Co Ltd Basic Information, Teriparatide API Manufacturing Base, Sales Area and Its Competitors
Table 99. Chengdu Shengnuo Biopharm Co Ltd Teriparatide API Product Portfolios and Specifications
Table 100. Chengdu Shengnuo Biopharm Co Ltd Teriparatide API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 101. Chengdu Shengnuo Biopharm Co Ltd Main Business
Table 102. Chengdu Shengnuo Biopharm Co Ltd Latest Developments
Table 103. Scinopharm Taiwan Ltd Basic Information, Teriparatide API Manufacturing Base, Sales Area and Its Competitors
Table 104. Scinopharm Taiwan Ltd Teriparatide API Product Portfolios and Specifications
Table 105. Scinopharm Taiwan Ltd Teriparatide API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 106. Scinopharm Taiwan Ltd Main Business
Table 107. Scinopharm Taiwan Ltd Latest Developments
Table 108. Auro Peptides Ltd Basic Information, Teriparatide API Manufacturing Base, Sales Area and Its Competitors
Table 109. Auro Peptides Ltd Teriparatide API Product Portfolios and Specifications
Table 110. Auro Peptides Ltd Teriparatide API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 111. Auro Peptides Ltd Main Business
Table 112. Auro Peptides Ltd Latest Developments
Table 113. Ambiopharm Inc Basic Information, Teriparatide API Manufacturing Base, Sales Area and Its Competitors
Table 114. Ambiopharm Inc Teriparatide API Product Portfolios and Specifications
Table 115. Ambiopharm Inc Teriparatide API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 116. Ambiopharm Inc Main Business
Table 117. Ambiopharm Inc Latest Developments
Table 118. Richter-Helm Biotec Gmbh And Co Kg Basic Information, Teriparatide API Manufacturing Base, Sales Area and Its Competitors
Table 119. Richter-Helm Biotec Gmbh And Co Kg Teriparatide API Product Portfolios and Specifications
Table 120. Richter-Helm Biotec Gmbh And Co Kg Teriparatide API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 121. Richter-Helm Biotec Gmbh And Co Kg Main Business
Table 122. Richter-Helm Biotec Gmbh And Co Kg Latest Developments
List of Figures
Figure 1. Picture of Teriparatide API
Figure 2. Teriparatide API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Teriparatide API Sales Growth Rate 2018-2029 (Tons)
Figure 7. Global Teriparatide API Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Teriparatide API Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Purity≥99%
Figure 10. Product Picture of Purity<99%
Figure 11. Global Teriparatide API Sales Market Share by Type in 2022
Figure 12. Global Teriparatide API Revenue Market Share by Type (2018-2023)
Figure 13. Teriparatide API Consumed in Injection
Figure 14. Global Teriparatide API Market: Injection (2018-2023) & (Tons)
Figure 15. Teriparatide API Consumed in Others
Figure 16. Global Teriparatide API Market: Others (2018-2023) & (Tons)
Figure 17. Global Teriparatide API Sales Market Share by Application (2022)
Figure 18. Global Teriparatide API Revenue Market Share by Application in 2022
Figure 19. Teriparatide API Sales Market by Company in 2022 (Tons)
Figure 20. Global Teriparatide API Sales Market Share by Company in 2022
Figure 21. Teriparatide API Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Teriparatide API Revenue Market Share by Company in 2022
Figure 23. Global Teriparatide API Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Teriparatide API Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Teriparatide API Sales 2018-2023 (Tons)
Figure 26. Americas Teriparatide API Revenue 2018-2023 ($ Millions)
Figure 27. APAC Teriparatide API Sales 2018-2023 (Tons)
Figure 28. APAC Teriparatide API Revenue 2018-2023 ($ Millions)
Figure 29. Europe Teriparatide API Sales 2018-2023 (Tons)
Figure 30. Europe Teriparatide API Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Teriparatide API Sales 2018-2023 (Tons)
Figure 32. Middle East & Africa Teriparatide API Revenue 2018-2023 ($ Millions)
Figure 33. Americas Teriparatide API Sales Market Share by Country in 2022
Figure 34. Americas Teriparatide API Revenue Market Share by Country in 2022
Figure 35. Americas Teriparatide API Sales Market Share by Type (2018-2023)
Figure 36. Americas Teriparatide API Sales Market Share by Application (2018-2023)
Figure 37. United States Teriparatide API Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Teriparatide API Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Teriparatide API Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Teriparatide API Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Teriparatide API Sales Market Share by Region in 2022
Figure 42. APAC Teriparatide API Revenue Market Share by Regions in 2022
Figure 43. APAC Teriparatide API Sales Market Share by Type (2018-2023)
Figure 44. APAC Teriparatide API Sales Market Share by Application (2018-2023)
Figure 45. China Teriparatide API Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Teriparatide API Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Teriparatide API Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Teriparatide API Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Teriparatide API Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Teriparatide API Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Teriparatide API Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Teriparatide API Sales Market Share by Country in 2022
Figure 53. Europe Teriparatide API Revenue Market Share by Country in 2022
Figure 54. Europe Teriparatide API Sales Market Share by Type (2018-2023)
Figure 55. Europe Teriparatide API Sales Market Share by Application (2018-2023)
Figure 56. Germany Teriparatide API Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Teriparatide API Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Teriparatide API Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Teriparatide API Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Teriparatide API Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Teriparatide API Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Teriparatide API Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Teriparatide API Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Teriparatide API Sales Market Share by Application (2018-2023)
Figure 65. Egypt Teriparatide API Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Teriparatide API Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Teriparatide API Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Teriparatide API Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Teriparatide API Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Teriparatide API in 2022
Figure 71. Manufacturing Process Analysis of Teriparatide API
Figure 72. Industry Chain Structure of Teriparatide API
Figure 73. Channels of Distribution
Figure 74. Global Teriparatide API Sales Market Forecast by Region (2024-2029)
Figure 75. Global Teriparatide API Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Teriparatide API Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Teriparatide API Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Teriparatide API Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Teriparatide API Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界のテリパラチド原薬市場予測 2023年-2029年] (コード：LP23DC02862)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のテリパラチド原薬市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のPVT高純度炭化ケイ素粉末市場予測 2023年-2029年
  • 世界の医薬品用高純度窒素市場予測 2023年-2029年
  • 世界のアメリシウム-243市場予測 2023年-2029年
  • 世界のバーケリウム-249市場予測 2023年-2029年
  • 世界のラジウム-224市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆